FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teri Klein

Research Profile

Occupations

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Concepts & Ideas

Physiology

Activities & Behaviors

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Mary Relling; W J Sandborn; K Schmiegelow; M Schwab; C M Stein; S W Yee; M Carrillo; William Evans; E E Gardner; J K Hicks; Ching-Hon Pui; Teri E Klein
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
Malin L Appell; Jonathan Berg; John Duley; William E Evans; Joan M Hebert; Martin A Kennedy; Teri E Klein; Lynne Lennard; Tony Marinaki; Ellen M McDonagh; Howard L McLeod; Mary V Relling; Elke Schaeffeler; Matthias Schwab; Richard Weinshilboum; Allen E J Yeoh; Sally A Coulthard
Nomenclature for alleles of the thiopurine methyltransferase gene.
Yogita Ghodke-Puranik; Russ B Altman; Angela K Birnbaum; Jatinder Lamba; J Steven Leeder; Wen Song; Caroline F Thorn; Teri E Klein
Valproic acid pathway: pharmacokinetics and pharmacodynamics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teri Klein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mary Relling; W J Sandborn; K Schmiegelow; M Schwab; C M Stein; S W Yee; M Carrillo; William Evans; E E Gardner; J K Hicks; Ching-Hon Pui; Teri E Klein
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
Clinical pharmacology and therapeutics 2013;93(4):324-5.
2013: Malin L Appell; Jonathan Berg; John Duley; William E Evans; Joan M Hebert; Martin A Kennedy; Teri E Klein; Lynne Lennard; Tony Marinaki; Ellen M McDonagh; Howard L McLeod; Mary V Relling; Elke Schaeffeler; Matthias Schwab; Richard Weinshilboum; Allen E J Yeoh; Sally A Coulthard
Nomenclature for alleles of the thiopurine methyltransferase gene.
Pharmacogenetics and genomics 2013;23(4):242-8.
2013: Yogita Ghodke-Puranik; Russ B Altman; Angela K Birnbaum; Jatinder Lamba; J Steven Leeder; Wen Song; Caroline F Thorn; Teri E Klein
Valproic acid pathway: pharmacokinetics and pharmacodynamics.
Pharmacogenetics and genomics 2013;23(4):236-41.
2012: Yogita Ghodke; Russ B Altman; Peter L Anderson; Jatinder Lamba; Katrin Sangkuhl; Teri E Klein
PharmGKB summary: zidovudine pathway.
Pharmacogenetics and genomics 2012;22(12):891-4.
2012: Li Gong; Srijib Goswami; Russ B Altman; Kathleen M Giacomini; Teri E Klein
Metformin pathways: pharmacokinetics and pharmacodynamics.
Pharmacogenetics and genomics 2012;22(11):820-7.
2012: M Whirl-Carrillo; E M McDonagh; Katrin Sangkuhl; Caroline Thorn; Russ B Altman; L Gong; J M Hebert; Teri E Klein
Pharmacogenomics knowledge for personalized medicine.
Clinical pharmacology and therapeutics 2012;92(4):414-7.
2012: Audrey H Poon; Benjamin A Raby; Scott T Weiss; Catherine Laprise; Augusto A Litonjua; Russ B Altman; Charlotte Brasch-Andersen; Li Gong; Qutayba Hamid; Teri E Klein
Very important pharmacogene summary for VDR.
Pharmacogenetics and genomics 2012;22(10):758-63.
2012: Ellen M McDonagh; Rachel F Tyndale; Catherine Wassenaar; Michelle Whirl-Carrillo; Russ B Altman; Sean P David; Teri E Klein
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.
Pharmacogenetics and genomics 2012;22(9):695-708.
2012: Caroline F Thorn; Richard M Weinshilboum; Russ B Altman; Yuan Ji; Teri E Klein
PharmGKB summary: very important pharmacogene information for GSTT1.
Pharmacogenetics and genomics 2012;22(8):646-51.
2012: Jatinder Lamba; Erin G Schuetz; Joan M Hebert; Teri E Klein; Russ B Altman
PharmGKB summary: very important pharmacogene information for CYP3A5.
Pharmacogenetics and genomics 2012;22(7):555-8.
2012: Caroline F Thorn; Michelle Whirl-Carrillo; Teri E Klein; J Steven Leeder; Russ B Altman
PharmGKB summary: phenytoin pathway.
Pharmacogenetics and genomics 2012;22(6):466-70.
2012: Caroline F Thorn; Eleni Aklillu; Teri E Klein; Ellen M McDonagh; Russ B Altman
PharmGKB summary: caffeine pathway.
Pharmacogenetics and genomics 2012;22(5):389-95.
2012: M A Martin; M Pirmohamed; Betty J Dong; D W Haas; Teri E Klein; Deanna L Kroetz
Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.
Clinical pharmacology and therapeutics 2012;91(4):734-8.
2012: Li Gong; Tilo Grosser; Russ B Altman; Monica M Bertagnolli; Caroline F Thorn; Teri E Klein
Celecoxib pathways: pharmacokinetics and pharmacodynamics.
Pharmacogenetics and genomics 2012;22(4):310-8.
2012: Ellen M McDonagh; Caroline F Thorn; Ilan Youngster; Russ B Altman; José M Bautista; Teri E Klein
PharmGKB summary: very important pharmacogene information for G6PD.
Pharmacogenetics and genomics 2012;22(3):219-28.
2012: Kristine R Crews; H M Dunnenberger; A Gaedigk; E D Kharasch; Teri E Klein; D D Shen; T C Skaar; J T Callaghan
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.
Clinical pharmacology and therapeutics 2012;91(2):321-6.
2012: Stuart A Scott; Alan R Shuldiner; Caroline F Thorn; Russ B Altman; Jean-Sébastien Hulot; Katrin Sangkuhl; Teri E Klein
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19.
Pharmacogenetics and genomics 2012;22(2):159-65.
2012: Fabio Rinaldi; Katrin Sangkuhl; Caroline F Thorn; Michelle Whirl-Carrillo; Simon Clematide; Yael Garten; Li Gong; Joan M Hebert; Teri E Klein; Russ B Altman
Using ODIN for a PharmGKB revalidation experiment.
Database : the journal of biological databases and curation 2012;2012():bas021.
2011: Ellen M McDonagh; Michelle Whirl-Carrillo; Russ B Altman; Yael Garten; Teri E Klein
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
Biomarkers in medicine 2011;5(6):795-806.
2011: Caroline F Thorn; John Kelsoe; Teri E Klein; Susan G Leckband; Daniel J Müller; J Steven Leeder; Russ B Altman
PharmGKB summary: carbamazepine pathway.
Pharmacogenetics and genomics 2011;21(12):906-10.
2011: Katrin Sangkuhl; Teri E Klein; Russ B Altman
PharmGKB summary: citalopram pharmacokinetics pathway.
Pharmacogenetics and genomics 2011;21(11):769-72.
2011: Mary Relling; D M Roden; H J Guchelaar; Teri E Klein
Pharmacogenetics: call to action.
Clinical pharmacology and therapeutics 2011;90(4):507; author reply 507-8.
2011: Torben S Mikkelsen; Mary V Relling; Caroline F Thorn; Cornelia M Ulrich; Jun J Yang; Gianluigi Zaza; Mara L Becker; Henry M Dunnenberger; William Evans; Deborah French; Roger Gaedigk; Kathy Giacomini; Leo Kager; Teri E Klein; James Steven Leeder; Sharon Marsh; Howard L McLeod; Russ B Altman
PharmGKB summary: methotrexate pathway.
Pharmacogenetics and genomics 2011;21(10):679-86.
2011: Caroline F Thorn; Tilo Grosser; Teri E Klein; Russ B Altman
PharmGKB summary: very important pharmacogene information for PTGS2.
Pharmacogenetics and genomics 2011;21(9):607-13.
2011: S A Scott; Alan R Shuldiner; C M Stein; E E Gardner; Jean-Sébastien Hulot; J A Johnson; Teri E Klein; Dan Mark Roden; Katrin Sangkuhl
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.
Clinical pharmacology and therapeutics 2011;90(2):328-32.
2011: Katrin Sangkuhl; Alan R Shuldiner; Teri E Klein; Russ B Altman
Platelet aggregation pathway.
Pharmacogenetics and genomics 2011;21(8):516-21.
2011: Caroline F Thorn; Tina Hernandez-Boussard; Teri E Klein; Sharon Marsh; Howard McLeod; Connie Oshiro; Russ B Altman
Doxorubicin pathways: pharmacodynamics and adverse effects.
Pharmacogenetics and genomics 2011;21(7):440-6.
2011: Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
PharmGKB summary: dopamine receptor D2.
Pharmacogenetics and genomics 2011;21(6):350-6.
2011: Dorit S Berlin; Katrin Sangkuhl; Teri E Klein; Russ B Altman
PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2.
Pharmacogenetics and genomics 2011;21(5):308-11.
2011: Caroline F Thorn; Sharon Marsh; Michelle Whirl Carrillo; Howard L McLeod; Teri E Klein; Russ B Altman
PharmGKB summary: fluoropyrimidine pathways.
Pharmacogenetics and genomics 2011;21(4):237-42.
2011: Mary Relling; E E Gardner; W J Sandborn; K Schmiegelow; Ching-Hon Pui; S W Yee; C M Stein; M Carrillo; William Evans; Teri E Klein
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
Clinical pharmacology and therapeutics 2011;89(3):387-91.
2011: Mary Relling; Teri E Klein
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
Clinical pharmacology and therapeutics 2011;89(3):464-7.
2011: Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).
Pharmacogenetics and genomics 2011;21(3):152-61.
2011: Marisa Wong Medina; Katrin Sangkuhl; Teri E Klein; Russ B Altman
PharmGKB: very important pharmacogene--HMGCR.
Pharmacogenetics and genomics 2011;21(2):98-101.
2011: Dale L Bodian; Randall J Radmer; Sean Holbert; Teri E Klein
Molecular dynamics simulations of the full triple helical region of collagen type I provide an atomic scale view of the protein's regional heterogeneity.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2011;():193-204.
2011: Li Gong; Russ B Altman; Teri E Klein
Bisphosphonates pathway.
Pharmacogenetics and genomics 2011;21(1):50-3.
2010: Connie Oshiro; Caroline F Thorn; Dan Mark Roden; Teri E Klein; Russ B Altman
KCNH2 pharmacogenomics summary.
Pharmacogenetics and genomics 2010;20(12):775-7.
2010: Sook Wah Yee; Li Gong; Ilaria Badagnani; Kathleen M Giacomini; Teri E Klein; Russ B Altman
SLC19A1 pharmacogenomics summary.
Pharmacogenetics and genomics 2010;20(11):708-15.
2010: Ryan P Owen; Li Gong; Hersh Sagreiya; Teri E Klein; Russ B Altman
VKORC1 pharmacogenomics summary.
Pharmacogenetics and genomics 2010;20(10):642-4.
2010: Gianluigi Zaza; Meyling Cheok; Natalia Krynetskaia; Caroline Thorn; Gabriele Stocco; Joan M Hebert; Howard McLeod; Richard M Weinshilboum; Mary V Relling; William E Evans; Teri E Klein; Russ B Altman
Thiopurine pathway.
Pharmacogenetics and genomics 2010;20(9):573-4.
2010: Caroline F Thorn; Jatinder K Lamba; Vishal Lamba; Teri E Klein; Russ B Altman
PharmGKB summary: very important pharmacogene information for CYP2B6.
Pharmacogenetics and genomics 2010;20(8):520-3.
2010: Katrin Sangkuhl; Teri E Klein; Russ B Altman
Clopidogrel pathway.
Pharmacogenetics and genomics 2010;20(7):463-5.
2010: Liewei Wang; Linda L Pelleymounter; Richard Weinshilboum; Julie A Johnson; Joan M Hebert; Russ B Altman; Teri E Klein
Very important pharmacogene summary: thiopurine S-methyltransferase.
Pharmacogenetics and genomics 2010;20(6):401-5.
2010: Kelly E Ormond; Matthew T Wheeler; Louanne Hudgins; Teri E Klein; Atul J Butte; Russ B Altman; Euan Ashley; Henry T Greely
Challenges in the clinical application of whole-genome sequencing.
Lancet 2010;375(9727):1749-51.
2010: Nita A Limdi; Mia Wadelius; Larisa H Cavallari; Niclas Eriksson; Dana C Crawford; Ming-Ta M Lee; Chien-Hsiun Chen; Alison Motsinger-Reif; Hersh Sagreiya; Nianjun Liu; Alan H B Wu; Brian F Gage; Andrea Jorgensen; Munir Pirmohamed; Jae-Gook Shin; Guilherme Suarez-Kurtz; Stephen E Kimmel; Julie A Johnson; Teri E Klein; Michael J Wagner
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Blood 2010;115(18):3827-34.
2010: Michael L Maitland; Xing Jian Lou; Jacqueline Ramirez; Apurva A Desai; Dorit S Berlin; Howard L McLeod; Ralph R Weichselbaum; Mark J Ratain; Russ B Altman; Teri E Klein
Vascular endothelial growth factor pathway.
Pharmacogenetics and genomics 2010;20(5):346-9.
2010: Caroline F Thorn; Teri E Klein; Russ B Altman
Pharmacogenomics and bioinformatics: PharmGKB.
Pharmacogenomics 2010;11(4):501-5.
2010: D S Berlin; M G Person; A Mittal; M A Oppezzo; D B Chin; B Starr; Teri E Klein; D L Schwartz; Russ B Altman
DNATwist: a Web-based tool for teaching middle and high school students about pharmacogenomics.
Clinical pharmacology and therapeutics 2010;87(4):393-5.
2010: Derek Van Booven; Sharon Marsh; howard mcleod; Michelle Whirl Carrillo; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Cytochrome P450 2C9-CYP2C9.
Pharmacogenetics and genomics 2010;20(4):277-81.
2010: Caroline F Thorn; Teri E Klein; Russ B Altman
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme.
Pharmacogenetics and genomics 2010;20(2):143-6.
2010: Augusto A Litonjua; Li Gong; Qing Ling Duan; Jaekyu Shin; Mariellen J Moore; Scott T Weiss; Julie A Johnson; Teri E Klein; Russ B Altman
Very important pharmacogene summary ADRB2.
Pharmacogenetics and genomics 2010;20(1):64-9.
2009: Katrin Sangkuhl; Teri E Klein; Russ B Altman
Selective serotonin reuptake inhibitors pathway.
Pharmacogenetics and genomics 2009;19(11):907-9.
2009: Sharon Marsh; howard mcleod; Eileen Dolan; Sunita J Shukla; Cara A Rabik; Li Gong; Tina Hernandez-Boussard; Xing Jian Lou; Teri E Klein; Russ B Altman
Platinum pathway.
Pharmacogenetics and genomics 2009;19(7):563-4.
2009: Ryan P Owen; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Cytochrome P450 2D6.
Pharmacogenetics and genomics 2009;19(7):559-62.
2009: Jun Yang; Alessia Bogni; Erin G Schuetz; Mark Ratain; M Eileen Dolan; howard mcleod; Li Gong; Caroline Thorn; Mary Relling; Teri E Klein; Russ B Altman
Etoposide pathway.
Pharmacogenetics and genomics 2009;19(7):552-3.
2009: Caroline F Thorn; Teri E Klein; Russ B Altman
Codeine and morphine pathway.
Pharmacogenetics and genomics 2009;19(7):556-8.
2009: Zeruesenay Desta; Anne Nguyen; David A Flockhart; Todd C Skaar; Rebecca Fletcher; Richard Weinshilboum; Dorit S Berlin; Teri E Klein; Russ B Altman
Antiestrogen pathway (aromatase inhibitor).
Pharmacogenetics and genomics 2009;19(7):554-5.
2009: Michelle Hildebrandt; Araba Adjei; Richard Weinshilboum; Julie A Johnson; Dorit S Berlin; Teri E Klein; Russ B Altman
Very important pharmacogene summary: sulfotransferase 1A1.
Pharmacogenetics and genomics 2009;19(6):404-6.
2009: Dale L Bodian; Teri E Klein
COLdb, a database linking genetic data to molecular function in fibrillar collagens.
Human mutation 2009;30(6):946-51.
2009: Dale L Bodian; Ting-Fung Chan; Annie Poon; Ulrike Schwarze; Kathleen Yang; Peter H Byers; Pui-Yan Kwok; Teri E Klein
Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships.
Human molecular genetics 2009;18(3):463-71.
2008: Li Gong; Ryan P Owen; Winston Gor; Russ B Altman; Teri E Klein
PharmGKB: an integrated resource of pharmacogenomic data and knowledge.
Current protocols in bioinformatics / editoral board, Andreas D. Baxevanis ... [et al.] 2008;Chapter 14():Unit14.7.
2008: Dale L Bodian; Balaraman Madhan; Barbara Brodsky; Teri E Klein
Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations.
Biochemistry 2008;47(19):5424-32.
2008: Ryan P Owen; Russ B Altman; Teri E Klein
PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Human mutation 2008;29(4):456-60.
2008: Ting-Fung Chan; Annie Poon; Analabha Basu; Nick R Addleman; Justin Chen; Angie Phong; Peter H Byers; Teri E Klein; Pui-Yan Kwok
Natural variation in four human collagen genes across an ethnically diverse population.
Genomics 2008;91(4):307-14.
2008: M Whirl-Carrillo; Mark Woon; Caroline Thorn; Teri E Klein; Russ B Altman
An XML-based interchange format for genotype-phenotype data.
Human mutation 2008;29(2):212-9.
2008: Katrin Sangkuhl; Dorit S Berlin; Russ B Altman; Teri E Klein
PharmGKB: understanding the effects of individual genetic variants.
Drug metabolism reviews 2008;40(4):539-51.
2008: Tina Hernandez-Boussard; Michelle Whirl-Carrillo; Joan M Hebert; Li Gong; Ryan Owen; Mei Gong; Winston Gor; Feng Liu; Chuong Truong; Ryan Whaley; Mark Woon; Tina Zhou; Russ B Altman; Teri E Klein
The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
Nucleic acids research 2008;36(Database issue):D913-8.
2007: Sanghyun Park; Teri E Klein; Vijay S Pande
Folding and misfolding of the collagen triple helix: Markov analysis of molecular dynamics simulations.
Biophysical journal 2007;93(12):4108-15.
2007: R P Owen; Teri E Klein; R B Altman
The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
Clinical pharmacology and therapeutics 2007;82(4):472-5.
2007: Russ B Altman; Teri E Klein
Biomedical informatics training at Stanford in the 21st century.
Journal of biomedical informatics 2007;40(1):55-8.
2007: A E Hodge; R B Altman; Teri E Klein
The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
Clinical pharmacology and therapeutics 2007;81(1):21-4.
2006: Tina Hernandez-Boussard; Teri E Klein; Russ B Altman
Pharmacogenomics: The relevance of emerging genotyping technologies.
MLO: medical laboratory observer 2006;38(3):24, 26-30.
2006: Randall J Radmer; Teri E Klein
Triple helical structure and stabilization of collagen-like molecules with 4(R)-hydroxyproline in the Xaa position.
Biophysical journal 2006;90(2):578-88.
2006: Tina Hernandez-Boussard; Mark Woon; Teri E Klein; Russ B Altman
Integrating large-scale genotype and phenotype data.
Omics : a journal of integrative biology 2006;10(4):545-54.
2005: Sanghyun Park; Randall J Radmer; Teri E Klein; Vijay S Pande
A new set of molecular mechanics parameters for hydroxyproline and its use in molecular dynamics simulations of collagen-like peptides.
Journal of computational chemistry 2005;26(15):1612-6.
2005: Daniel L Rubin; Caroline Thorn; Teri E Klein; Russ B Altman
A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge.
Journal of the American Medical Informatics Association : JAMIA 2005;12(2):121-9.
2005: Caroline Thorn; Teri E Klein; Russ B Altman
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
Methods in molecular biology (Clifton, N.J.) 2005;311():179-91.
2004: Randall J Radmer; Teri E Klein
Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
Biochemistry 2004;43(18):5314-23.
2004: Daniel L Rubin; Michelle Carrillo; Mark Woon; John Conroy; Teri E Klein; Russ B Altman
A resource to acquire and summarize pharmacogenetics knowledge in the literature.
Studies in health technology and informatics 2004;107(Pt 2):793-7.
2003: D Rey Banatao; Russ B Altman; Teri E Klein
Microenvironment analysis and identification of magnesium binding sites in RNA.
Nucleic acids research 2003;31(15):4450-60.
2003: Mike P Liang; D Rey Banatao; Teri E Klein; Douglas L Brutlag; Russ B Altman
WebFEATURE: An interactive web tool for identifying and visualizing functional sites on macromolecular structures.
Nucleic acids research 2003;31(13):3324-7.
2003: Sean D Mooney; Teri E Klein; Russ B Altman; Mark Trifiro; Bruce Gottlieb
A functional analysis of disease-associated mutations in the androgen receptor gene.
Nucleic acids research 2003;31(8):e42.
2003: Shuo Liu; Steve Lin; Mark Woon; Teri E Klein; Russ B Altman
A personalized and automated dbSNP surveillance system.
Proceedings / IEEE Computer Society Bioinformatics Conference. IEEE Computer Society Bioinformatics Conference 2003;2():132-6.
2003: Russ B Altman; David A Flockhart; Stephen T Sherry; Diane E Oliver; Daniel L Rubin; Teri E Klein
Indexing pharmacogenetic knowledge on the World Wide Web.
Pharmacogenetics 2003;13(1):3-5.
2002: Sean D Mooney; Teri E Klein
Structural models of osteogenesis imperfecta-associated variants in the COL1A1 gene.
Molecular & cellular proteomics : MCP 2002;1(11):868-75.
2002: Sean D Mooney; Teri E Klein
The functional importance of disease-associated mutation.
BMC bioinformatics 2002;3():24.
2002: Sean D Mooney; Peter A Kollman; Teri E Klein
Conformational preferences of substituted prolines in the collagen triple helix.
Biopolymers 2002;64(2):63-71.
2002: Michelle L Green; Teri E Klein
A multidomain TIGR/olfactomedin protein family with conserved structural similarity in the N-terminal region and conserved motifs in the C-terminal region.
Molecular & cellular proteomics : MCP 2002;1(5):394-403.
2002: Daniel L Rubin; Micheal Hewett; Diane E Oliver; Teri E Klein; Russ B Altman
Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2002;():88-99.
2002: Diane E Oliver; Daniel L Rubin; Josh M Stuart; Micheal Hewett; Teri E Klein; Russ B Altman
Ontology development for a pharmacogenetics knowledge base.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2002;():65-76.
2002: Russ B Altman; Teri E Klein
Challenges for biomedical informatics and pharmacogenomics.
Annual review of pharmacology and toxicology 2002;42():113-33.
2002: Micheal Hewett; Diane E Oliver; Daniel L Rubin; Katrina L Easton; Josh M Stuart; Russ B Altman; Teri E Klein
PharmGKB: the Pharmacogenetics Knowledge Base.
Nucleic acids research 2002;30(1):163-5.
2001: Sean D Mooney; C C Huang; Peter A Kollman; Teri E Klein
Computed free energy differences between point mutations in a collagen-like peptide.
Biopolymers 2001;58(3):347-53.
2001: Teri E Klein; Jeffrey T Chang; M K Cho; K L Easton; R Fergerson; Micheal Hewett; Zhen Lin; Y Liu; S Liu; Diane E Oliver; Daniel L Rubin; F Shafa; Josh M Stuart; Russ B Altman
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base.
The pharmacogenomics journal 2001;1(3):167-70.
2001: D Rey Banatao; Conrad C Huang; Patricia C Babbitt; Russ B Altman; Teri E Klein
ViewFeature: integrated feature analysis and visualization.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2001;():240-50.
2000: Conrad C Huang; Walter R P Novak; Patricia C Babbitt; A I Jewett; Thomas E Ferrin; Teri E Klein
Integrated tools for structural and sequence alignment and analysis.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2000;():230-41.
1999: D K Hendrix; Teri E Klein; Irwin D Kuntz; T E Klien
Macromolecular docking of a three-body system: the recognition of human growth hormone by its receptor.
Protein science : a publication of the Protein Society 1999;8(5):1010-22.
1999: Teri E Klein; C C Huang
Computational investigations of structural changes resulting from point mutations in a collagen-like peptide.
Biopolymers 1999;49(2):167-83.
1998: Cynthia D Selassie; W X Gan; L S Kallander; Teri E Klein
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.
Journal of medicinal chemistry 1998;41(22):4261-72.
1998: Conrad C Huang; Gregory S Couch; Eric F Pettersen; Thomas E Ferrin; A E Howard; Teri E Klein
The object technology framework: an object-oriented interface to molecular data and its application to collagen.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 1998;():349-61.
1991: C C Huang; E F Pettersen; Teri E Klein; Tom E. Ferrin; R Langridge
Conic: a fast renderer for space-filling molecules with shadows.
Journal of molecular graphics 1991;9(4):230-6, 242.
1991: Cesar Compadre; Corwin Hansch; Teri E Klein; J Petridou-Fischer; Cynthia D Selassie; R N Smith; W Steinmetz; C Z Yang; G Z Yang
Separation of electronic and hydrophobic effects for the papain hydrolysis of substituted N-benzoylglycine esters.
Biochimica et biophysica acta 1991;1079(1):43-52.
1991: Corwin Hansch; Teri E Klein
Quantitative structure-activity relationships and molecular graphics in evaluation of enzyme-ligand interactions.
Methods in enzymology 1991;202():512-43.
1990: Cesar Compadre; Corwin Hansch; Teri E Klein; R Langridge
The structure-activity relationship of the papain hydrolysis of N-benzoylglycine esters.
Biochimica et biophysica acta 1990;1038(2):158-63.
1990: Teri E Klein; C C Huang; E F Pettersen; G S Couch; Tom E. Ferrin; R Langridge
A real-time malleable molecular surface.
Journal of molecular graphics 1990;8(1):16-24, 26.
1989: Cynthia D Selassie; Z X Fang; R L Li; Corwin Hansch; G Debnath; Teri E Klein; R Langridge; B T Kaufman
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
Journal of medicinal chemistry 1989;32(8):1895-905.
1988: A Carotti; C Raguseo; Teri E Klein; R Langridge; Corwin Hansch
QSAR analysis of the subtilisin hydrolysis of X-phenyl hippurates. II. A study of subtilisin BPN'.
Chemico-biological interactions 1988;67(3-4):171-84.
1987: Maurizio Recanatini; Teri E Klein; R Langridge; Corwin Hansch
Concanavalin X-phenyl beta-D-glucopyranoside interactions. A molecular graphics-QSAR analysis.
Il Farmaco; edizione scientifica 1987;42(12):879-91.
1987: Lewis B Morgenstern; Maurizio Recanatini; Teri E Klein; W Steinmetz; C Z Yang; R Langridge; Corwin Hansch
Chymotrypsin hydrolysis of X-phenyl hippurates. A quantitative structure-activity relationship and molecular graphics analysis.
The Journal of biological chemistry 1987;262(22):10767-72.